Recruiting Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease NCT03300830 Conditions Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Castleman Disease, +30 more Locations National Institutes of Health Clinical Center — Bethesda, Maryland, United States View Trial Details
Recruiting International Registry for Patients With Castleman Disease NCT02817997 Conditions Angiofollicular Lymph Hyperplasia, Angiofollicular Lymph Node Hyperplasia, Angiofollicular Lymphoid Hyperplasia, +13 more Locations University of Pennsylvania — Philadelphia, Pennsylvania, United States View Trial Details
Recruiting Registry for Adults With Plasma Cell Disorders (PCD's) NCT03717844 Conditions Abnormalities, Multiple, Amyloidosis, Blood Protein Disorders, +40 more Locations North Carolina Cancer Hospital — Chapel Hill, North Carolina, United States View Trial Details
Recruiting A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH NCT05283993 Conditions Abnormalities, Multiple, Amyloidosis, Blood Protein Disorders, +44 more Locations Peking University First Hospital — Beijing, China View Trial Details
Completed Unlock the Cell: Castleman's Disease Flow Cytometry Study NCT02853968 Conditions Angiofollicular Lymph Hyperplasia, Angiofollicular Lymphoid Hyperplasia, Castleman Disease, +13 more Locations University of Pennsylvania — Philadelphia, Pennsylvania, United States View Trial Details
Completed A Study to Provide RoActemra/Actemra (Tocilzumab) to Patients With Multicentric Castleman's Disease Who Demonstrated Benefit From Previous RoActemra/Actemra Treatment NCT01183598 Conditions Castleman Disease, Castleman's Disease, Hemic and Lymphatic Diseases, +4 more Locations Little Rock, Arkansas, United States View Trial Details
